Ellen Morgan is one of the founders and driving forces behind Agility Clinical, one of the most recommended CROs in the western US. Her passion for helping underserved patient populations has helped to define Agility’s focus on orphan drug development. Prior to Agility, Ellen was founder and CEO of Synteract from 1995-2010, and Chairman in 2011. She built Synteract to become a full-service, international contract research organization serving biopharma companies, with offices in 3 locations in the US and Europe. Ellen is also the founder of PHACT, the first non-profit CRO specializing in clinical trials for neglected diseases in Africa. She has earned numerous awards including “Most Admired CEO”, “100 Most Inspiring People in the Pharmaceutical Industry”, “Athena Pinnacle Award for Women in Science and Technology”, and Ernst & Young “Entrepreneur of the Year” Finalist. Her prior positions include large pharmaceutical companies (Sterling Drug and Pfizer) and Gensia, a biotechnology company. Ellen has a BS in Chemistry, and an MS in Management & Industrial Engineering from Rensselaer Polytechnic Institute.      

Clinical Research